BrightSpring Health Services (NASDAQ:BTSG) Price Target Raised to $41.00 at Bank of America

BrightSpring Health Services (NASDAQ:BTSGGet Free Report) had its target price boosted by investment analysts at Bank of America from $38.00 to $41.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Bank of America‘s target price points to a potential upside of 15.12% from the stock’s current price.

Other research analysts also recently issued research reports about the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of BrightSpring Health Services in a research report on Monday, December 1st. BTIG Research boosted their target price on BrightSpring Health Services from $30.00 to $41.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Mizuho set a $38.00 price objective on BrightSpring Health Services in a research note on Wednesday, October 29th. Wall Street Zen downgraded shares of BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 15th. Finally, UBS Group boosted their target price on BrightSpring Health Services from $35.00 to $42.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $36.64.

Get Our Latest Report on BTSG

BrightSpring Health Services Stock Up 3.1%

NASDAQ:BTSG traded up $1.08 during trading hours on Tuesday, reaching $35.62. The company’s stock had a trading volume of 483,727 shares, compared to its average volume of 2,500,819. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.79 and a quick ratio of 1.38. The company has a market cap of $6.42 billion, a price-to-earnings ratio of 58.41, a price-to-earnings-growth ratio of 0.60 and a beta of 2.36. The business’s 50-day moving average is $32.46 and its 200-day moving average is $26.37. BrightSpring Health Services has a one year low of $15.26 and a one year high of $36.77.

BrightSpring Health Services (NASDAQ:BTSGGet Free Report) last announced its earnings results on Monday, October 20th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.27 by $0.03. BrightSpring Health Services had a net margin of 1.04% and a return on equity of 11.61%. The firm had revenue of $3.33 billion for the quarter, compared to the consensus estimate of $3.16 billion. BrightSpring Health Services has set its Q3 2025 guidance at 0.300-0.300 EPS. Equities research analysts predict that BrightSpring Health Services will post 0.59 EPS for the current year.

Insider Activity at BrightSpring Health Services

In other BrightSpring Health Services news, insider Lisa A. Nalley sold 20,000 shares of BrightSpring Health Services stock in a transaction dated Wednesday, October 22nd. The stock was sold at an average price of $28.78, for a total transaction of $575,600.00. Following the transaction, the insider directly owned 131,150 shares of the company’s stock, valued at approximately $3,774,497. The trade was a 13.23% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jon B. Rousseau sold 235,000 shares of BrightSpring Health Services stock in a transaction on Wednesday, October 22nd. The shares were sold at an average price of $28.78, for a total transaction of $6,763,300.00. Following the completion of the sale, the insider owned 1,131,930 shares of the company’s stock, valued at $32,576,945.40. This represents a 17.19% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 3.40% of the company’s stock.

Institutional Trading of BrightSpring Health Services

Several hedge funds have recently made changes to their positions in the company. CIBC Bancorp USA Inc. bought a new stake in BrightSpring Health Services during the 3rd quarter worth approximately $296,000. Oberweis Asset Management Inc. raised its stake in shares of BrightSpring Health Services by 17.0% during the third quarter. Oberweis Asset Management Inc. now owns 908,000 shares of the company’s stock valued at $26,840,000 after acquiring an additional 132,200 shares during the last quarter. NewEdge Advisors LLC increased its position in BrightSpring Health Services by 7.2% during the 3rd quarter. NewEdge Advisors LLC now owns 39,768 shares of the company’s stock valued at $1,176,000 after purchasing an additional 2,674 shares during the period. Alyeska Investment Group L.P. lifted its stake in shares of BrightSpring Health Services by 19.0% in the 3rd quarter. Alyeska Investment Group L.P. now owns 1,984,365 shares of the company’s stock valued at $58,658,000 after purchasing an additional 316,965 shares during the period. Finally, Verition Fund Management LLC lifted its holdings in shares of BrightSpring Health Services by 19.4% during the third quarter. Verition Fund Management LLC now owns 183,361 shares of the company’s stock valued at $5,420,000 after purchasing an additional 29,795 shares during the last quarter.

BrightSpring Health Services Company Profile

(Get Free Report)

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

Featured Stories

Analyst Recommendations for BrightSpring Health Services (NASDAQ:BTSG)

Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.